Tivic Health Systems Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	1.18	1.84	1.26	0.86	0.42
Revenue Growth (YoY)	-36.09%	46.38%	46.16%	104.76%	-
Cost of Revenue	0.89	1.54	1.3	1.09	0.71
Gross Profit	0.29	0.3	-0.04	-0.23	-0.29
Selling, General & Admin	6.88	8.67	4.72	2.32	2.36
Research & Development	1.66	1.73	0.88	0.66	0.99
Operating Expenses	8.53	10.4	5.6	2.98	3.35
Operating Income	-8.25	-10.1	-5.63	-3.2	-3.64
Interest Expense / Income	0	0	1.82	0.42	0.44
Other Expense / Income	-0	-0	1.04	0.01	0.06
Pretax Income	-8.24	-10.1	-8.49	-3.64	-4.15
Income Tax	0	0	0	0	0
Net Income	-8.24	-10.1	-8.49	-3.64	-4.15
Shares Outstanding (Basic)	1	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0	0
Shares Change	719.45%	177.04%	51.67%	0.14%	-
EPS (Basic)	-10.40	-104.32	-243.00	-158.00	-180.00
EPS (Diluted)	-10.40	-104.32	-243.00	-158.00	-180.00
Free Cash Flow	-8.63	-8.93	-5.61	-3.03	-3.7
Free Cash Flow Per Share	-10.88	-92.27	-160.65	-131.42	-160.91
Gross Margin	24.40%	16.25%	-3.02%	-26.16%	-68.81%
Operating Margin	-701.11%	-548.80%	-448.13%	-372.56%	-867.38%
Profit Margin	-701.02%	-548.70%	-675.74%	-423.14%	-987.62%
Free Cash Flow Margin	-733.76%	-485.33%	-446.46%	-351.98%	-881.19%
EBITDA	-8.06	-9.92	-6.65	-3.21	-3.7
EBITDA Margin	-685.54%	-539.24%	-528.80%	-373.02%	-880.71%
Depreciation & Amortization	0.18	0.17	0.02	0.01	0
EBIT	-8.24	-10.1	-6.67	-3.22	-3.7
EBIT Margin	-701.02%	-548.70%	-530.71%	-373.95%	-881.67%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).